234 related articles for article (PubMed ID: 19743495)
1. Early treatment for non-ST-segment elevation acute coronary syndrome is associated with appropriate discharge care.
Fermann GJ; Raja AS; Peterson ED; Roe MT; Hoekstra JW; Milford-Beland S; Diercks DB; Pollack CV; Peacock WF; Summers R; Ohman EM; Gibler WB
Clin Cardiol; 2009 Sep; 32(9):519-25. PubMed ID: 19743495
[TBL] [Abstract][Full Text] [Related]
2. The causes and outcomes of inadequate implementation of existing guidelines for antiplatelet treatment in patients with acute coronary syndrome: the experience from Taiwan Acute Coronary Syndrome Descriptive Registry (T-ACCORD Registry).
Cheng CI; Chen CP; Kuan PL; Lei MH; Liau CS; Ueng KC; Wu CJ; Lai WT
Clin Cardiol; 2010 Jun; 33(6):E40-8. PubMed ID: 20552592
[TBL] [Abstract][Full Text] [Related]
3. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?
Silva MA; Donovan JL; Gandhi PJ; Volturo GA
Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468
[TBL] [Abstract][Full Text] [Related]
4. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
Mehta RH; Roe MT; Chen AY; Lytle BL; Pollack CV; Brindis RG; Smith SC; Harrington RA; Fintel D; Fraulo ES; Califf RM; Gibler WB; Ohman EM; Peterson ED
Arch Intern Med; 2006 Oct; 166(18):2027-34. PubMed ID: 17030838
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge.
Tricoci P; Roe MT; Mulgund J; Newby LK; Smith SC; Pollack CV; Fintel DJ; Cannon CP; Bhatt DL; Gibler WB; Ohman EM; Peterson ED; Harrington RA
Arch Intern Med; 2006 Apr; 166(7):806-11. PubMed ID: 16606819
[TBL] [Abstract][Full Text] [Related]
6. The usage patterns of cardiac bedside markers employing point-of-care testing for troponin in non-ST-segment elevation acute coronary syndrome: results from CRUSADE.
Takakuwa KM; Ou FS; Peterson ED; Pollack CV; Peacock WF; Hoekstra JW; Ohman EM; Gibler WB; Blomkalns AL; Roe MT
Clin Cardiol; 2009 Sep; 32(9):498-505. PubMed ID: 19743496
[TBL] [Abstract][Full Text] [Related]
7. Managing acute coronary syndrome: evidence-based approaches.
Spinler SA
Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S14-24. PubMed ID: 17519441
[TBL] [Abstract][Full Text] [Related]
8. Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative.
Hoekstra JW; Pollack CV; Roe MT; Peterson ED; Brindis R; Harrington RA; Christenson RH; Smith SC; Ohman EM; Gibler WB
Acad Emerg Med; 2002 Nov; 9(11):1146-55. PubMed ID: 12414463
[TBL] [Abstract][Full Text] [Related]
9. Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement Initiative.
Tickoo S; Roe MT; Peterson ED; Milford-Beland S; Ohman EM; Gibler WB; Pollack CV; Cannon CP;
Am J Cardiol; 2007 Jun; 99(11):1496-9. PubMed ID: 17531568
[TBL] [Abstract][Full Text] [Related]
10. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?).
Sonel AF; Good CB; Mulgund J; Roe MT; Gibler WB; Smith SC; Cohen MG; Pollack CV; Ohman EM; Peterson ED;
Circulation; 2005 Mar; 111(10):1225-32. PubMed ID: 15769762
[TBL] [Abstract][Full Text] [Related]
11. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
12. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery.
Mehta RH; Roe MT; Mulgund J; Ohman EM; Cannon CP; Gibler WB; Pollack CV; Smith SC; Ferguson TB; Peterson ED
J Am Coll Cardiol; 2006 Jul; 48(2):281-6. PubMed ID: 16843176
[TBL] [Abstract][Full Text] [Related]
13. Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy.
Mehta SR; Bassand JP; Chrolavicius S; Diaz R; Fox KA; Granger CB; Jolly S; Rupprecht HJ; Widimsky P; Yusuf S;
Am Heart J; 2008 Dec; 156(6):1080-1088.e1. PubMed ID: 19033002
[TBL] [Abstract][Full Text] [Related]
14. Approach to non-ST-segment elevation acute coronary syndrome in the emergency department: risk stratification and treatment strategies.
Lefebvre CW; Hoekstra J
Hosp Pract (1995); 2010 Apr; 38(2):40-9. PubMed ID: 20469612
[TBL] [Abstract][Full Text] [Related]
15. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
Lee HY; Cooke CE; Robertson TA
J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
[TBL] [Abstract][Full Text] [Related]
16. An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence.
Chandra A; Glickman SW; Ou FS; Peacock WF; McCord JK; Cairns CB; Peterson ED; Ohman EM; Gibler WB; Roe MT
Ann Emerg Med; 2009 Jul; 54(1):17-25. PubMed ID: 19282062
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of optimized antithrombotic therapy with aspirin, clopidogrel and enoxaparin in patients with non-ST segment elevation acute coronary syndromes in clinical practice.
Heer T; Juenger C; Gitt AK; Bauer T; Towae F; Zahn R; Senges J; Zeymer U;
J Thromb Thrombolysis; 2009 Oct; 28(3):325-32. PubMed ID: 19101783
[TBL] [Abstract][Full Text] [Related]
18. The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis.
Rogowski W; Burch J; Palmer S; Craigs C; Golder S; Woolacott N
Health Technol Assess; 2009 Jun; 13(31):iii-iv, ix-xi, 1-77. PubMed ID: 19573471
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE).
Cohen MG; Roe MT; Mulgund J; Peterson ED; Sonel AF; Menon V; Smith SC; Saucedo JF; Lytle BL; Pollack CV; Garza L; Gibler WB; Ohman EM
Am Heart J; 2006 Jul; 152(1):110-7. PubMed ID: 16824839
[TBL] [Abstract][Full Text] [Related]
20. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative.
Diercks DB; Roe MT; Mulgund J; Pollack CV; Kirk JD; Gibler WB; Ohman EM; Smith SC; Boden WE; Peterson ED
Am Heart J; 2006 Jul; 152(1):140-8. PubMed ID: 16824844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
